These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27218463)

  • 21. Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury.
    Nozawa Y; Matsuura N; Miyake H; Yamada S; Kimura R
    Life Sci; 1999; 64(22):2061-70. PubMed ID: 10374931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of neointimal hyperplasia in rats treated with atorvastatin after carotid artery injury may be mainly associated with down-regulation of survivin and Fas expression.
    Xu Y; Zhou S; Fang Z; Li X; Huang D; Liu Q; Zheng C
    Pharm Biol; 2014 Sep; 52(9):1196-203. PubMed ID: 25116077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic Fatty rats.
    Buglak NE; Jiang W; Bahnson ESM
    Redox Biol; 2018 Oct; 19():166-178. PubMed ID: 30172101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compound K, an intestinal metabolite of ginsenosides, inhibits PDGF-BB-induced VSMC proliferation and migration through G1 arrest and attenuates neointimal hyperplasia after arterial injury.
    Park ES; Lee KP; Jung SH; Lee DY; Won KJ; Yun YP; Kim B
    Atherosclerosis; 2013 May; 228(1):53-60. PubMed ID: 23473423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transmembrane protein 66 attenuates neointimal hyperplasia after carotid artery injury by SOCE inactivation.
    Yang J; Li S; Wang Q; Yang D
    Mol Med Rep; 2019 Aug; 20(2):1436-1442. PubMed ID: 31173198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of nitric oxide on neointimal hyperplasia based on sex and hormone status.
    Hogg ME; Varu VN; Vavra AK; Popowich DA; Banerjee MN; Martinez J; Jiang Q; Saavedra JE; Keefer LK; Kibbe MR
    Free Radic Biol Med; 2011 May; 50(9):1065-74. PubMed ID: 21256959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periadventitial atRA citrate-based polyester membranes reduce neointimal hyperplasia and restenosis after carotid injury in rats.
    Gregory EK; Webb AR; Vercammen JM; Flynn ME; Ameer GA; Kibbe MR
    Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1419-29. PubMed ID: 25239800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gingerol Inhibits Serum-Induced Vascular Smooth Muscle Cell Proliferation and Injury-Induced Neointimal Hyperplasia by Suppressing p38 MAPK Activation.
    Jain M; Singh A; Singh V; Maurya P; Barthwal MK
    J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):187-200. PubMed ID: 26240073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coptisine inhibits neointimal hyperplasia through attenuating Pak1/Pak2 signaling in vascular smooth muscle cells without retardation of re-endothelialization.
    Chen Y; Jiang X; Yuan Y; Chen Y; Wei S; Yu Y; Zhou Q; Yu Y; Wang J; Liu H; Hua X; Yang Z; Chen Z; Li Y; Wang Q; Chen J; Wang Y
    Atherosclerosis; 2024 Apr; 391():117480. PubMed ID: 38447436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor.
    Gennaro G; Ménard C; Michaud SE; Deblois D; Rivard A
    Circulation; 2004 Nov; 110(21):3367-71. PubMed ID: 15520324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction.
    Kim SY; Kwon YW; Jung IL; Sung JH; Park SG
    Cardiovasc Res; 2011 Nov; 92(2):307-16. PubMed ID: 21840882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA GAS5 regulates vascular smooth muscle cell cycle arrest and apoptosis via p53 pathway.
    Tang R; Mei X; Wang YC; Cui XB; Zhang G; Li W; Chen SY
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2516-2525. PubMed ID: 31167125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor.
    Choe N; Kwon JS; Kim YS; Eom GH; Ahn YK; Baik YH; Park HY; Kook H
    Cell Signal; 2015 Jun; 27(6):1056-65. PubMed ID: 25683915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
    Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
    FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of Protein Kinase G (PKG) Reduces Neointimal Hyperplasia, Inhibits Platelet Aggregation, and Facilitates Re-endothelialization.
    Kim JY; Yang HM; Lee JE; Kim BK; Jin S; Lee J; Park KW; Cho HJ; Kwon YW; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
    Sci Rep; 2016 Nov; 6():36979. PubMed ID: 27833146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CKLF1 aggravates neointimal hyperplasia by inhibiting apoptosis of vascular smooth muscle cells through PI3K/AKT/NF-κB signaling.
    Duan Y; Zhang Y; Qu C; Yu W; Tana ; Shen C
    Biomed Pharmacother; 2019 Sep; 117():108986. PubMed ID: 31387172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The herbal extract HMC05 inhibits neointima formation in balloon-injured rat carotid arteries: possible therapeutic implications of HMC05.
    Lee JW; Lee BS; Lee JY; Ku HJ; Jeon SR; Kim JY; Ban JM; Sung SH; Shin HM; Park JE
    J Ethnopharmacol; 2011 Jan; 133(1):168-76. PubMed ID: 20883768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of polycomb repressor complex 2 ameliorates neointimal hyperplasia by suppressing trimethylation of H3K27 in vascular smooth muscle cells.
    Liang J; Li Q; Cai W; Zhang X; Yang B; Li X; Jiang S; Tian S; Zhang K; Song H; Ai D; Zhang X; Wang C; Zhu Y
    Br J Pharmacol; 2019 Sep; 176(17):3206-3219. PubMed ID: 31162630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kanglexin counters vascular smooth muscle cell dedifferentiation and associated arteriosclerosis through inhibiting PDGFR.
    Yang S; Zhao Y; Cao S; Liu X; Feng M; Chen Y; Ma C; Zhan T; Zhang Q; Jia H; Zhao Y; Tong M; Yu Y; Liu X; Yang B; Zhang Y
    Phytomedicine; 2024 Jul; 130():155704. PubMed ID: 38759316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.